Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
10/1999
10/13/1999CN1231694A Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
10/13/1999CN1231693A An enzyme with amylase activity
10/13/1999CN1231692A Novel phytase and process for the preparation thereof
10/13/1999CN1231691A An enzyme with cyclomaltodextrin glucanotransferase (CGTASE) activity
10/13/1999CN1231689A Detergent composition comprising two cellulose components, with and without a cellulose-binding domain
10/13/1999CN1231618A Biodegradation of metal cyanides
10/13/1999CN1045620C Process for preparing DNA construction with preceding sequence of kluyveromyces X-factor directing heterologous polypeptide excretion
10/12/1999US5965796 Metal resistance sequences and transgenic plants
10/12/1999US5965795 Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a beta-C-4-oxygenase activity for biotechnological production of (3S, 3'S) astaxanthin and its specific expression in chromoplasts of higher plants
10/12/1999US5965793 Strong early seed-specific gene regulatory region
10/12/1999US5965789 Engineering protein posttranslational modification by PACE/furin in transgenic non-human mammals
10/12/1999US5965727 For selectable markers and promoters for plant tissue culture transformation
10/12/1999US5965711 A protein; anticarcinogenic/antiarthritic/antidiabetic agents; treatment of addison's and crohn's disease, multiple sclerosis, scleroderma, ulcers, respiratory disorders; fungicides, viricides, bactericides
10/12/1999US5965692 Anticoagulants for treatment of thromobosis and hypercoagulability in blood and tissues
10/12/1999US5965510 Enhancement of enzyme reactions
10/12/1999US5965444 Method for constructing transformant not having selective marker gene
10/12/1999US5965443 A mutant transposase enzyme having greater avidity for outside repeat sequences of donor dna; genetic engineering for introducing desired genetic changes to a nucleic acid
10/12/1999US5965442 Method of altering enzymes and a novel neopullulanase
10/12/1999US5965440 Retroviral vector containing dna operatively linked with three different promters, a tetracyline regulatory unit under transcritpional control of the second promoter, an antisense orientated tetracycline response unit; gene therapy
10/12/1999US5965435 Genetically engineered genes containing the herpes virus of turkeys gc gene, thymidine kinase region of marek's disease virus, infectious laryngotracheitis virus's open reading frame and ribonucleotide reductase genes; for vaccines
10/12/1999US5965431 Increasing bioavailability of compounds and mixtures by setting temperature of aqueous medium to 45 degrees celsius or higher and using culture of thermophilic bacteria; solvent-free for pollution control
10/12/1999US5965426 A protein; for effecient secretory production of heterologous proteins
10/12/1999US5965425 Expression of pace in host cells and methods of use thereof
10/12/1999US5965424 Mutating the immunoglobulin a protease gene to inactivate c-terminal helper sequence, transforming cells, culturing and expressing recombinant gene as inclusion bodies, isolating inclusion bodies, converting to active protease
10/12/1999US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents
10/12/1999US5965422 Lysophospholipase produced from aspergillus by recombinant methods
10/12/1999US5965421 Human IRAK-2
10/12/1999US5965420 A protein which stimulates cell proliferation; treatment of bone loss due to osteoporosis; treat adult respiratory disease syndrome, parkinson'disease, huntington's disease; antiarthritic/anticarcinogenic agents; antiallergens
10/12/1999US5965419 Purified sulfotransferase
10/12/1999US5965418 A protein which catalyzes the oxidation of halide ions in the presence of hydrogen peroxide; microbiocides
10/12/1999US5965417 Arabidepsi thaliana proteins having Δ-5,7-sterol-Δ-7-reductase activity
10/12/1999US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999US5965412 For phosphorolysis of kojibiose in presence of phosphoric acid and/or salt forming d-glucose and beta-d-glucose-1-phosphoric acid and/or salt; for transfer of glucosyl group to other saccharides producing oligosaccharides
10/12/1999US5965411 Maltose-trehalose converting enzyme, and preparation and uses thereof
10/12/1999US5965406 A genetically engineered molecule having a cell-binding domain, a translocation domain covalently bond to a toxin and an enzymatically active polypeptide; gene therapy, treatment of acquired immune deficieny syndrome
10/12/1999US5965402 DNA encoding phoH polypeptides
10/12/1999US5965396 Human lymph node derived GTPase
10/12/1999US5965391 A structural gene positioned in front of a malate synthase gene which enables controlled expression of desired proteins in corynebacterium by inducing agents added to the medium; genetic engineering
10/12/1999US5965389 Yeast which is transformed with dna construct of regulatory sequences and dna sequence coding glutamate decarboxylase isoform; for high level gene expression and industrial production of enzyme for screening and monitoring of diabetes
10/12/1999US5965386 Yeast strains and modified albumins
10/12/1999US5965384 Culturing aspergillus oryzae transformed with expression vector of regulatory sequences and dna sequences coding for humicola lanuginosa lipase, recovering lipase with different glycosylation and heat and/or proteolytic resistance
10/12/1999US5965383 Fibrin binding domain polypeptides and uses and methods of producing same
10/12/1999US5965373 Identifying enzyme inhibitors by combining a dimeric protein with a substrate, and a compound believed to be an inhibitor and determining activity of the protein on the substrate; diagnosis of epithelial cancer
10/12/1999US5965372 An antibody that binds the oxidized nicotinamide-adenine dinucleotide dependent isoform of 11 beta-hydroxysteriod dehydrogenase-2; hypotensive agent, screening of in vitro fertilization
10/12/1999US5965369 A protein; diagnosis/treatment for reproductive disorders, gastrointestinal disorders, aquired immune deficiency syndrome, parkison's/alzheimer's/huntington's disease; anticarcinogenic/antiinflammatory/antidiabetic agents
10/12/1999US5965365 A human growth factor receptor binding gene; treatment and diagnosis of smooth muscle disorders; antiproliferative/ anticarcinogenic/antitumor agents
10/12/1999US5965350 Cloning and expression of human GMP synthetase, its use in screening for inhibitors of human GMP synthetase and inhibitors of human GMP synthetase
10/12/1999US5965157 Method to provide for production of hair coloring pigments in hair follicles
10/12/1999US5965129 Purified cathepsin polypeptide and amino acid sequence or immunologically active fragments thereof; administering the novel protein with a pharmaceutical carrier to treat cancer
10/12/1999US5965126 use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents
10/12/1999CA2112423C Non-reducing saccharide-forming enzyme, and its preparation and uses
10/12/1999CA2096851C Tissue plasminogen activator substitution variant
10/07/1999WO1999050453A1 Method for searching steroid sulfatase inhibitors
10/07/1999WO1999050432A1 Inducible alphaviral gene expression system
10/07/1999WO1999050430A2 Modification of fatty acid composition in plants by expression of an aspergillus nidulans delta-9 coa desaturase
10/07/1999WO1999050423A2 Isochorismate synthase and its use for the induction of resistance in plants
10/07/1999WO1999050422A2 Method for reduction of fusel oils in alcoholic beverages and food products
10/07/1999WO1999050421A1 Ubiquitin conjugating enzyme
10/07/1999WO1999050420A1 Method for increasing the phenoxy propionic acid hydroxylation rate
10/07/1999WO1999050403A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999WO1999050400A1 Amp deaminase
10/07/1999WO1999050399A2 Non-maltogenic exoamylases and their use in retarding retrogradation of starch
10/07/1999WO1999050398A2 Recombinant anti-tumor rnase
10/07/1999WO1999050397A2 Immobilized nuclease from serratia marcescens
10/07/1999WO1999050396A1 Nek1-related protein kinase
10/07/1999WO1999050395A1 Serine-threonine protein kinase expressed in kidney
10/07/1999WO1999050392A1 Methods and compositions for eliciting an immune response to a telomerase antigen
10/07/1999WO1999050389A1 Microbial strains and processes for the manufacture of biomaterials
10/07/1999WO1999050386A2 Human telomerase catayltic subunit variants
10/07/1999WO1999050380A1 An acidic cleaning composition comprising an acidic protease
10/07/1999WO1999050307A1 Complexes for immobilising isothiocyanate natural precursors in cyclodextrins, preparation and use
10/07/1999WO1999050279A1 Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
10/07/1999WO1999050278A1 Compositions and methods for the identification of lung tumor cells
10/07/1999WO1999049880A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999WO1999049879A1 Sequence and method for genetic engineering of proteins with cell membrane translocating activity
10/07/1999WO1999040182A3 CRYSTALLINE TNF-α-CONVERTING ENZYME AND USES THEREOF
10/07/1999WO1999035169A3 Methods and compositions for treating and diagnosing insulin related disorders
10/07/1999WO1999029880A3 Method for producing transgenic plants with modified 5-aminolevulinic acid biosynthesis, method for identifying 5-aminolevulinic acid synthesis effectors
10/07/1999WO1999022005A3 Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor
10/07/1999WO1999015668A3 Banana proteins, dna, and dna regulatory elements associated with fruit development
10/07/1999DE19913206A1 Production of CMP-sialate synthetase protein useful for producing CMP-activated N-acetylneuraminic acid analogs and non-naturally sialylated oligosaccharides and glycoconjugates
10/07/1999DE19814963A1 MAPKAP Kinase 2-Hemmer und ihre Verwendung für die anti-inflammatorische Therapie MAPKAP kinase 2 inhibitors and their use for the anti-inflammatory therapy
10/07/1999DE19814925A1 Arzneimittel zur Induktion zytotoxischer T-Zellen Drugs for the induction of cytotoxic T cells
10/07/1999DE19814860A1 Bakterielle Transglutaminasen Bacterial transglutaminases
10/07/1999DE19814528A1 Verfahren zur Erhöhung der POPS-Hydroxylierungsrate A method for increasing the POPs hydroxylation
10/07/1999CA2347067A1 Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer
10/07/1999CA2333433A1 Salicylic acid pathway genes and their use for the induction of resistance in plants
10/07/1999CA2326588A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999CA2325564A1 Inducible alphaviral gene expression system
10/07/1999CA2325054A1 Amp deaminase
10/07/1999CA2324973A1 Method for increasing the phenoxy propionic acid hydroxylation rate
10/07/1999CA2324652A1 Nek1-related protein kinase
10/07/1999CA2324646A1 Recombinant anti-tumor rnase
10/07/1999CA2324424A1 Method for searching steroid sulfatase inhibitors
10/07/1999CA2324421A1 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999CA2323833A1 Compositions and methods for the identification of lung tumor cells
10/06/1999EP0947142A2 Method for cross-linking protein by using enzyme
10/06/1999EP0946755A1 Methods and compositions for polypeptide engineering
10/06/1999EP0946737A2 Herbicide resistant plants
10/06/1999EP0946732A2 Method for the recombinant production of 1,3-propanediol